Literature DB >> 17917329

Sarcoidosis accompanied by systemic lupus erythematosus and autoimmune hepatitis.

Seiko Nakayama1, Hiroshi Mukae, Tomohito Morisaki, Noriho Sakamoto, Kazuo Ohba, Koh Abe, Fuminao Takeshima, Yohei Mizuta, Hiroaki Ida, Yoshiyuki Ozono, Shigeru Kohno.   

Abstract

A 52-year-old woman was admitted to our hospital for further examination of blurred vision, abnormal lung shadows and an elevated level of angiotensin-converting enzyme. Sarcoidosis was suspected, however, careful history taking revealed the existence of photosensitivity and polyarthralgia. Laboratory tests showed lymphocytopenia, liver dysfunction, hypergammaglobulinemia, and positive anti-nuclear, anti-double stranded DNA and anti-smooth muscle antibodies. Liver biopsy examination showed chronic active hepatitis. She was diagnosed with the triplex of sarcoidosis, systemic lupus erythematosus and autoimmune hepatitis. Marked improvement was noted after corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917329     DOI: 10.2169/internalmedicine.46.0201

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Neurosarcoidosis Presenting with Prominent Periventricular White-Matter Lesions during Steroid Treatment for Autoimmune Hepatitis.

Authors:  Tomoya Shibahara; Fumitaka Yoshino; Mikiaki Matsuoka; Masaki Tachibana; Kuniyuki Nakamura; Tetsuro Ago; Junya Kuroda; Hiroshi Nakane
Journal:  Case Rep Neurol       Date:  2022-08-19

2.  High rate of cardiac sarcoidosis presenting with cutaneous plaque type sarcoidosis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography: a case series.

Authors:  Satoshi Nakamura; Yoshio Hashimoto; Kaoru Nishi; Keiko Takeda; Toshihiro Mizumoto; Toshio Demitsu; Hajime Iizuka
Journal:  J Med Case Rep       Date:  2014-01-15

3.  Autoantibodies against cytoskeletons and lysosomal trafficking discriminate sarcoidosis from healthy controls, tuberculosis and lung cancers.

Authors:  Samer Najeeb Hanoudi; Harvinder Talwar; Sorin Draghici; Lobelia Samavati
Journal:  Mol Biomed       Date:  2022-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.